PROGNOSIS IN SCHIZOPHRENIA - INDIVIDUAL-DIFFERENCES IN PSYCHOLOGICAL RESPONSE TO A TEST DOSE OF ANTIPSYCHOTIC DRUG AND THEIR RELATIONSHIP TO BLOOD AND SALIVA LEVELS AND TREATMENT OUTCOME

被引：6
|
作者：
MAY, PRA [1 ]
VANPUTTEN, T [1 ]
JENDEN, DJ [1 ]
YALE, C [1 ]
DIXON, WJ [1 ]
GOLDSTEIN, MJ [1 ]
机构：
[1] UNIV CALIF LOS ANGELES,SCH MED,INST NEUROPSYCHIAT,LOS ANGELES,CA 90024
来源：
COMPREHENSIVE PSYCHIATRY | 1981年 / 22卷 / 02期
关键词：
D O I：
10.1016/0010-440X(81)90062-6
中图分类号：
R749 [精神病学];
学科分类号：
100205 ;
摘要：
引用
收藏
页码：147 / 152
页数：6
相关论文
共 10 条
  • [1] TEST DOSE-RESPONSE IN SCHIZOPHRENIA - CHLORPROMAZINE BLOOD AND SALIVA LEVELS
    MAY, PRA
    VANPUTTEN, T
    JENDEN, DJ
    CHO, AK
    ARCHIVES OF GENERAL PSYCHIATRY, 1978, 35 (09) : 1091 - 1097
  • [2] Exploration of a dose-response relationship in schizophrenia with the novel antipsychotic drug olanzapine
    Kinon, BJ
    Wang, L
    Gilmore, JA
    BIOLOGICAL PSYCHIATRY, 2001, 49 (08) : 131S - 131S
  • [3] Exploration of a dose-response relationship in schizophrenia with the novel antipsychotic drug olanzapine
    Kinon, BJ
    Wang, L
    Gilmore, JA
    INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 2002, 17 : S9 - S9
  • [4] Exploration of a dose-response relationship in schizophrenia with the novel antipsychotic drug olanzapine
    Kinon, BJ
    Gilmore, J
    Wang, L
    SCHIZOPHRENIA RESEARCH, 2001, 49 (1-2) : 234 - 235
  • [5] Treatment strategies in case of non-response in schizophrenia: increasing the antipsychotic dose or switching the antipsychotic drug versus continuation of the same antipsychotic dose or drug
    Samara, M.
    Leucht, S.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2016, 26 : S562 - S562
  • [6] A PRELIMINARY ATTEMPT TO RELATE INDIVIDUAL-DIFFERENCES IN EEG TEST DOSE-RESPONSE TO CLINICAL EFFECT
    MAY, PRA
    ITIL, T
    VANPUTTEN, T
    LEE, MA
    YALE, C
    BIOLOGICAL PSYCHIATRY, 1982, 17 (05) : 599 - 603
  • [7] PREDICTING INDIVIDUAL RESPONSES TO DRUG-TREATMENT IN SCHIZOPHRENIA - TEST DOSE MODEL
    MAY, PRA
    VANPUTTEN, T
    YALE, C
    POTEPAN, P
    JENDEN, DJ
    FAIRCHILD, MD
    GOLDSTEIN, MJ
    DIXON, WJ
    JOURNAL OF NERVOUS AND MENTAL DISEASE, 1976, 162 (03) : 177 - 183
  • [8] Melperone, an atypical antipsychotic drug, in the treatment of schizophrenia: dose-response analysis on effectiveness and tolerability, and efficacy for treatment-resistant schizophrenia and cognitive function
    Sumiyoshi, T
    Meltzer, HY
    Jayathilake, K
    INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 2004, 19 (03) : 184 - 184
  • [9] Sex differences in the peripheral levels of cytokines during 12-month antipsychotic treatment in a drug-naïve schizophrenia spectrum cohort
    Ratke, I.
    Torsvik, A.
    Bartz-Johannessen, C. A.
    Fathian, F.
    Joa, I.
    Reitan, S. M. Klaebo
    Loberg, E. M.
    Rettenbacher, M.
    Skrede, S.
    Steen, V. M.
    Johnsen, E.
    Kroken, R. A.
    BRAIN BEHAVIOR & IMMUNITY-HEALTH, 2025, 44
  • [10] Anterior Cingulate Cortex Glutamate Levels Are Related to Response to Initial Antipsychotic Treatment in Drug-Naive First-Episode Schizophrenia Patients
    Li, Jinguang
    Ren, Honghong
    He, Ying
    Li, ZongChang
    Ma, Xiaoqian
    Yuan, Liu
    Ouyang, Lijun
    Zhou, Jun
    Wang, Dong
    Li, Chunwang
    Chen, Xiaogang
    Han, Hongying
    Tang, Jinsong
    FRONTIERS IN PSYCHIATRY, 2020, 11
1